Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
November 26, 2025 Off

Century Therapeutics to Participate in Piper Sandler 37th Annual Healthcare Conference

By GlobeNewswire

PHILADELPHIA, Nov. 25, 2025 (GLOBE NEWSWIRE) — Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), a biotechnology company developing induced pluripotent stem…

November 26, 2025 Off

Scilex Holding Company Announces Closing of Exercise of Warrants for $20.3 Million Gross Proceeds

By GlobeNewswire

PALO ALTO, Calif., Nov. 25, 2025 (GLOBE NEWSWIRE) — Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative…

November 26, 2025 Off

IPSEN – Buy-back programme – Art 5 of MAR – Week 47 – 2025

By GlobeNewswire

   Aggregated presentation by day and by marketStatement of transactions in own shares from November 17th to November 21st 2025       Name…

November 26, 2025 Off

Branded Legacy Announces Strong Revenues from Newly Acquired Pau Hana Subsidiary

By GlobeNewswire

Pau Hana Plans Ambitious Expansion Roadmap and New Location Acquisitions in the PipelineMELBOURNE, Fla., Nov. 25, 2025 (GLOBE NEWSWIRE) —…

November 25, 2025 Off

Junshi Biosciences Announces Primary Endpoints Met in JS001sc’s Phase 3 Study for the 1ST-line Treatment of NSQ-NSCLC

By GlobeNewswire

SHANGHAI, Nov. 24, 2025 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading…

November 25, 2025 Off

Ascentage Pharma Announces Publication of Olverembatinib Phase Ib Safety, Efficacy and Novel Mechanism Data in Gastrointestinal Stromal Tumors in Nature’s Signal Transduction and Targeted Therapy

By GlobeNewswire

Largest prospective clinical trial to-date in a rare subtype of GIST ROCKVILLE, Md. and SUZHOU, China, Nov. 24, 2025 (GLOBE…

November 25, 2025 Off

Mesoblast Trading Update at Annual General Meeting Highlights Continued Strong Growth in Ryoncil® Revenue

By GlobeNewswire

NEW YORK, Nov. 24, 2025 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory…

November 25, 2025 Off

Novartis receives FDA approval for Itvisma®, the only gene replacement therapy for children two years and older, teens, and adults with spinal muscular atrophy (SMA)

By GlobeNewswire

Ad hoc announcement pursuant to Art. 53 LR Itvisma (onasemnogene abeparvovec-brve) demonstrated improved motor function and stabilization in patients regardless…

November 25, 2025 Off

Onco360® Has Been Selected as The National Specialty Pharmacy Partner for HYRNUO® (sevabertinib)

By GlobeNewswire

LOUISVILLE, Ky., Nov. 24, 2025 (GLOBE NEWSWIRE) — Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as the…

November 25, 2025 Off

Eton Pharmaceuticals to Present at Piper Sandler 37th Annual Healthcare Conference on December 4th

By GlobeNewswire

DEER PARK, Ill., Nov. 24, 2025 (GLOBE NEWSWIRE) — Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative…

Posts pagination

Previous 1 … 44 45 46 … 3,605 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine